Stock CRUCELL
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News CRUCELL

Equities

NL0000358562

End-of-day quote Euronext Amsterdam
Other stock markets
- EUR - Intraday chart for CRUCELL

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Crucell N.V. : JUDGMENT ISSUED IN CRUCELL N.V. BUY-OUT PROCEEDINGS
PU
CRUCELL : JUDGMENT ISSUED IN CRUCELL N.V. BUY-OUT PROCEEDINGS
GL
CRUCELL : Discovers Important New Antibody Against Influenza A
GL
CRUCELL : Intends to Delist Ordinary Shares on NYSE Euronext
GL
CRUCELL : Johnson & Johnson Acquires 98.89% of Issued Crucell Shares as of the End of the Subsequent Offering Period and Crucell Intends to Delist Crucell Ordinary Shares and ADSs
GL
CRUCELL : Johnson & Johnson Completes Tender Offer for Crucell and Declares Offer Unconditional
GL
CRUCELL : Minimum Acceptance Condition Satisfied
GL
CRUCELL : Shareholders Adopt Offer Governance Resolutions and Johnson & Johnson Makes Announcement on U.S. Regulatory Matters
GL
CRUCELL : Reports Fourth Quarter and Full Year 2010 Results
GL
CRUCELL : Johnson & Johnson Launches Recommended Public Offer to Acquire Crucell
GL
CRUCELL : Johnson & Johnson and Crucell Progress Update: Expect to Commence Public Offer Prior to 10 December 2010
GL
CRUCELL : Reports Third Quarter 2010 Results
GL
CRUCELL : Johnson & Johnson and Crucell Provide Progress Update on Preparations for Public Offer
GL
CRUCELL : Notice of Extraordinary General Meeting of Shareholders
GL
CRUCELL : Puts Temporary Hold on Shipments of Quinvaxem and Hepavax-Gene
GL
CRUCELL : to Convene Initial Informational Extraordinary General Meeting of Shareholders to Discuss Johnson & Johnson Offer
GL
CRUCELL : Johnson & Johnson and Crucell Reach Agreement on Intended Public Offer of ?24.75 per Ordinary Share of Crucell
GL
CRUCELL : Aeras and Crucell Announce Phase II Clinical Trial Start in Kenya
GL
CRUCELL : Johnson & Johnson and Crucell in advanced negotiations for an all cash public offer of EUR24.75 per ordinary share of Crucell
GL
CRUCELL : Reports Record Revenues in Second Quarter 2010
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News CRUCELL